The highlights from the February Board Meeting are now available.
Amendments to the Pharmacy Operations and Drug Scheduling Act (PODSA) permit the College to know the identity of all pharmacy owners, determine their suitability for pharmacy ownership and hold them accountable for providing safe and effective care by ensuring their pharmacies are compliant with legislative requirements for pharmacies in BC.
While these amendments were originally slated...
Tracey Hagkull and Justin Thind have been appointed by Minister of Health, Adrian Dix, to serve as public board members for a term of two years. Ryan Hoag has been appointed for...
Opioid Agonist Treatment Alert: Potential Slow Release Oral Morphine Shortage
From The British Columbia Centre on Substance Use
On January 1, 2018, amendments to Professional Practice Policy – 66, including changing its name from “Methadone Maintenance Treatment” to “Opioid Agonist Treatment,” came into effect. These amendments also include the introduction of new policy guides for buprenorphine/naloxone, and slow-release oral morphine.
On December 20, 2017, BC’s Minister of Mental Health and Addictions, Judy Darcy announced that take-home naloxone kits are now available at community pharmacies throughout British Columbia.
Required maintenance work to the College’s IT systems supporting eServices will take place between 5:00 pm Saturday, December 16 and 12:00pm Sunday, December 17.
Each year, the UBC Faculty of Pharmaceutical Science recognizes one of its remarkable alumni for creating a local, provincial, national or global impact in the field of community, research, hospital, governance, education or clinical pharmacy.
The College of Pharmacists of British Columbia would like to congratulate our Registrar, Bob Nakagawa, for being this year’s recipient.
On November 7, 2017, Health Canada implemented changes regarding the prescribing and dispensing of Mifegymiso.
The highlights from the November Board Meeting are now available.